September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
August 2025
The neurotech devices market size was valued at USD 14.75 billion in 2024 and is projected to worth around USD 55.79 billion by 2034 with a CAGR of 13.84%.
September 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.90 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global remote neurological monitoring market size was evaluated at USD 2.81 billion in 2026 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 14.80%.
September 2026
The neurological biomarkers market size reached USD 11.66 billion in 2026 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 128.39 billion in 2026 with a CAGR of 6.07%.
August 2025
The global spinal imaging market size was calculated at USD 2.09 billion in 2024 and is predicted to attain around USD 3.49 billion by 2034, with a CAGR of 5.26%.
August 2025
The U.S. pantoprazole market size was evaluated at USD 743.96 million in 2024 and is predicted to hit around USD 1,302.87 million by 2034, growing at a CAGR of 5.76%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com